Clinical Trial Update: Adderall XR and Cognitive Impairment in MS [Phase 2, Phase 3]

View source ↗

Summary

This update describes a Phase 2/Phase 3 clinical trial evaluating Adderall XR for cognitive impairment in individuals with multiple sclerosis. The study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Adderall XR (mixed amphetamine salts)

Snippet

Sponsor: Sarah Morrow | Conditions: Multiple Sclerosis | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING